Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burden

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
Journal of Clinical Medicine|August 7, 2021
Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 PatientsDavid F Niedrig, Ali Rahmany, Kai Heib, et al.
British Journal of Clinical Pharmacology|July 6, 2018
Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UKMarina Simeonova, Frank de Vries, Sander Pouwels, et al.
British Journal of Clinical Pharmacology|March 23, 2017
Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulantsLeo M Stolk, Frank de Vries, Chiel Ebbelaar, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and PharmacologyNavnath Gavande, Izumi Yamamoto, Noeris K Salam, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 21, 2025
A scoping review of real-world evidence generation methods to estimate the safety of type 2 diabetes medications on fracture riskMaria C Spagnuolo, Freddy F Shogry, Stephen Park, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2022
Bone fragility in diabetes: novel concepts and clinical implicationsLorenz C Hofbauer, Björn Busse, Richard Eastell, et al.
European Journal of Clinical Pharmacology|November 26, 2020
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practiceStefan Russmann, Ali Rahmany, David Niedrig, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2011
The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK studyRoss Sadler, Roger W Chapman, Dawn Simpson, et al.
European Journal of Clinical Pharmacology|April 10, 2020
Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims dataAnnika M Jödicke, Andrea M Burden, Urs Zellweger, et al.
Cancer Research|August 20, 2009
Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migrationAdam M Burgoyne, Polly J Phillips-Mason, Susan M Burden-Gulley, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|August 7, 2021
Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 PatientsDavid F Niedrig, Ali Rahmany, Kai Heib, et al.
British Journal of Clinical Pharmacology|July 6, 2018
Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UKMarina Simeonova, Frank de Vries, Sander Pouwels, et al.
British Journal of Clinical Pharmacology|March 23, 2017
Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulantsLeo M Stolk, Frank de Vries, Chiel Ebbelaar, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and PharmacologyNavnath Gavande, Izumi Yamamoto, Noeris K Salam, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 21, 2025
A scoping review of real-world evidence generation methods to estimate the safety of type 2 diabetes medications on fracture riskMaria C Spagnuolo, Freddy F Shogry, Stephen Park, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2022
Bone fragility in diabetes: novel concepts and clinical implicationsLorenz C Hofbauer, Björn Busse, Richard Eastell, et al.
European Journal of Clinical Pharmacology|November 26, 2020
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practiceStefan Russmann, Ali Rahmany, David Niedrig, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2011
The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK studyRoss Sadler, Roger W Chapman, Dawn Simpson, et al.
European Journal of Clinical Pharmacology|April 10, 2020
Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims dataAnnika M Jödicke, Andrea M Burden, Urs Zellweger, et al.
Cancer Research|August 20, 2009
Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migrationAdam M Burgoyne, Polly J Phillips-Mason, Susan M Burden-Gulley, et al.
Pageof 19